Skip to content

The demonstration and promotion of Traditional Chinese Medicine clinical guidelines for lung cancer: Curative effect observation on intervention of Ttaditional Chinese Medicine sport Baduanjin on postoperative non-small cell lung cancer patients

The demonstration and promotion of Traditional Chinese Medicine clinical guidelines for lung cancer: Curative effect observation on intervention of Ttaditional Chinese Medicine sport Baduanjin on postoperative non-small cell lung cancer patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-14005430
Enrollment
Unknown
Registered
2014-09-01
Start date
2014-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NSCLC

Interventions

research group:Sport of Baduanjin

Sponsors

Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Non-small cell lung cancer patients of I-IIIA period diagnosed by pathology or cytology; (2) post operation more than a month, who need to receive postoperative radiotherapy or chemotherapy treatment has completed 3-4 months' adjuvant treatment; (3) ECOG (Eastern Cooperative Oncology Group performance status): 0-1, KPS (Karnofsky Performance Status): 80-100; (4) Aged 18 to 75 years old; (5) The Prediction of the Survival Time longer than at least 6 months; (6) Patient who has a good compliance, understands the situation of research and signs a consent form.

Exclusion criteria

Exclusion criteria: (1) Patient with indefinite pathological diagnosis; (2) Patients with serious, uncontrolled organic diseases or infections, such as heart failure, collapsed lung, renal failure,etc; (3) Patients with psychological disorder or extremity function disturbance can't take part in the sport activity; (4) Pregnant or lactating women; (5) In other clinical trials.

Design outcomes

Primary

MeasureTime frame
6-minutes walk test;FEV1 (Forced expiratory volume in one second);FVC (forced vital capacity);FEV1/ FVC;

Secondary

MeasureTime frame
QOL (quality of life);clinical symptoms;DFS (disease-free survival);clinical symptoms;immunologic function;

Countries

China

Contacts

Public ContactLin Hongsheng
drlinhongsheng@163.com+86 010-88001192

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026